Ji Hwan Bang

Ji Hwan Bang

Auto-generated profile, based on publicly available information

Ji Hwan Bang

Division of Infectious Diseases, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
EKEu Suk Kim
Eu Suk Kim
BCBum Sik Chin
Bum Sik Chin
CKChang Kyung Kang
Chang Kyung Kang
NKNam Joong Kim
Nam Joong Kim
KYKang Yumin
Kang Yumin
OCon behalf of the Korea National Committee for Clinical Management of COVID-19
on behalf of the Korea National Committee for Clinical Management of COVID-19
Kim ES, et al. J Korean Med Sci. 2020 Feb;35(13):e142. https://doi.org/10.3346/jkms.2020.35.e142

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
EKEu Suk Kim
Eu Suk Kim
PCPyoeng Gyun Choe
Pyoeng Gyun Choe
WPWan Beom Park
Wan Beom Park
HOHong Sang Oh
Hong Sang Oh
EKEun Jung Kim
Eun Jung Kim
MOMyoung-Don Oh
Myoung-Don Oh
Kim ES, et al. J Korean Med Sci. 2016 Nov;31(11):1717-1725. https://doi.org/10.3346/jkms.2016.31.11.1717

1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
MKMin-Kyung Kim
Min-Kyung Kim
BLBora Lee
Bora Lee
YCYoun Young Choi
Youn Young Choi
JUJihye Um
Jihye Um
KLKyung-Shin Lee
Kyung-Shin Lee
JJJaehyun Jeon
Jaehyun Jeon
Kim MK, et al. J Korean Med Sci. 2022 Jan;37(3):e31. https://doi.org/10.3346/jkms.2022.37.e31

16 February 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JKJungmee Kim
Jungmee Kim
ELEunyoung Lee
Eunyoung Lee
BPByung-Joo Park
Byung-Joo Park
JBJi Hwan Bang
Ji Hwan Bang
JLJin Yong Lee
Jin Yong Lee
For ideal clinical benefit, human immunodeficiency virus (HIV)-infected individuals should receive continuous medication. This is the first nationwide antiretroviral therapy (ART) adherence study in Asia, where medication monitoring at national level is systemically available. We estimated the ART adherence of incident HIV-infected individuals and investigated factors affecting low medication adherence using the national health insurance (NHI) claims data from 2007 to 2016. Medication possession ratio (MPR) was used to measure medication adherence and risk factors were identified by multivariable logistic regression analysis. Of the 8,501 newly diagnosed HIV-infected individuals during 2009–2016 with at least one ART prescription, 70.4% of HIV patients had adequate adherence to ART defined as MPR ≥95%. Requiring prophylactic antibiotics, female gender, age of 0–19 and same or over 50 s compared to 30–39, and having a history of malignancy, lower socioeconomic status, not visiting tertiary hospital, and being diagnosed in the earlier years were risk factors for lower adherence (Odds ratio 1.7, 1.6, 1.6, 1.4, 1.6, 2.1, 1.2, and 1.6 to 3.8 respectively). Health authority should take into consideration of these modifiable and unmodifiable barriers to establish sustainable monitoring system at national level and to improve adherence.

1 January 2018 in Journal of Korean Medical Science
Verified
Journal Article
Open access
WPWan Beom Park
Wan Beom Park
KJKang Il Jun
Kang Il Jun
GKGayeon Kim
Gayeon Kim
JCJae-Phil Choi
Jae-Phil Choi
JRJi-Young Rhee
Ji-Young Rhee
HSHyoung-shik Shin
Hyoung-shik Shin
Park WB, et al. J Korean Med Sci. 2018 May;33(24):e169. https://doi.org/10.3346/jkms.2018.33.e169

26 July 2015 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MLMyung Jin Lee
Myung Jin Lee
MKMoonsuk Kim
Moonsuk Kim
NKNak-Hyun Kim
Nak-Hyun Kim
CKChung-Jong Kim
Chung-Jong Kim
KSKyoung-Ho Song
Kyoung-Ho Song
HKHong Bin Kim
Hong Bin Kim
Asymptomatic bacteriuria (ABU) is common and often leads to unnecessary antimicrobial use. Reducing antibiotic overuse for ABU is therefore an important issue for antimicrobial stewardship. We performed this study to investigate the appropriateness of ABU management and to evaluate physicians’ knowledge and practice regarding ABU. We reviewed all urine cultures of ≥105 cfu/mL of bacteria among inpatients in a 900-bed hospital in 2011. Each episode of bacteriuria was classified into ABU or urinary tract infection (UTI). ABU was defined as a positive urine culture (≥105 cfu/mL) without symptoms or signs suggesting UTI. In October 2012 a cross-sectional survey of resident physicians was undertaken using an anonymous, self-administered questionnaire. We identified 219 ABU cases among 1167 positive urine cultures, of which 70 (32.0 %) were inappropriately treated. Female gender, old age, pyuria, hematuria, and positive nitrite on urinalysis were associated with inappropriate ABU treatment in a multivariate analysis (P < 0.05). The response rate to the survey was 74.2 % (95/128). The mean knowledge score was 37.3 %, and 33.7 % of respondents were able to distinguish ABU from UTI, but less than half knew the indications for treating ABU. Even after ABU was correctly diagnosed, concerns about postoperative infections (38.6 %), UTI (9.1 %), and abnormal urinalysis (29.5 %) prevented proper management. About half of the respondents reported to prescribing antibiotics for ABU despite knowing they were not indicated. About one third of ABUs were inappropriately managed. Lack of knowledge and discrepancies between knowledge and practice, contributed to antimicrobial overuse for ABU. Our findings highlight the importance of developing interventions, including education, audit and feedback, to tackle the problem of inappropriate treatment of ABU.